Recalls

Imprimis Recall Unapproved Ophthalmic In

Imprimis NJOF recalled three intraocular ophthalmic injection drug products in December 2025 (as per USFDA

Zydus Recalls Antipsychotic Drug for Nit

Zydus is recalling multiple lots of the antipsychotic drug Chlorpromazine in U.S due to the

Alembic Recalls Anti-depressant Medicine

Alembic recently initiated recall of antidepressant drug Doxepin Hydrochloride Capsules (10 mg) in US for Nitrosamine

Loss of Potency: Accord / Intas Recall H

Accord (Intas) initiated a recall of several lots of Levothyroxine tablets in the US for

Concerns of Beta-lactam Contamination Tr

In March 2025, Glenmark initiated recall of 23 products (148 lots) in US for cGMP

Chattem Inc Recall Antihistamine Sleepin

First Recall of Diphenhydramine HCl for NDSRI With timelines closing in for drug product manufacturers

NDSRIs: Glenmark Recalls Several Lots of

Glenmark Pharmaceuticals is recalling several lots of the cardiovascular drug Carvedilol in US due to

Growing Trend of Drug Recalls for NDSRIs

Adding to the number of recalls during 2024 for NDSRIs, Ascend (Alkem) is recalling the

API Key SM Source Concerns: Lupin Recall

Authored by: Venkiteswaran.T.K, Subrangshu Chourdhary, Satish Reddy Lupin is recalling over 600,000 bottles of Ramipril capsules across different

Nitrosocinacalcet Nitrosamine Impurity T

In October 2024, Accord Healthcare recalled over 25 lots of Cinacalcet tablets in various strengths